Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Clinical trial NCT00861744 · COMPLETED

Trial details

NCT number: NCT00861744
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rubella Mumps Measles Measles-Mumps-Rubella Vaccine

Start date: 2009-06-03
Primary completion: 2010-07-21
Enrollment: 1259

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.